Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, tolerability, and efficacy of topical SM04554 solution in men with androgenetic alopecia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• SM04554 (SM04554)

Snippet

Sponsor: Biosplice Therapeutics, Inc. | Conditions: Androgenetic Alopecia | Phase 2 | Status: COMPLETED